Mannkind (MNKD) Invested Capital (2010 - 2026)
Mannkind (MNKD) reported Invested Capital of -$48.8 million for Q1 2026, down 0.56% year-over-year from -$49.1 million in Q1 2025, and down 19.89% quarter-over-quarter from -$40.7 million in Q4 2025.
Mannkind (MNKD) Invested Capital (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Invested Capital data on file, last reported at -$48.8 million in Q1 2026.
- Invested Capital for Q1 2026 came in at -$48.8 million, down 0.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$48.8 million (down 0.56% YoY), and the FY2025 annual result was -$40.7 million, up 40.81% from the prior year.
- Invested Capital fell to -$48.8 million in Q1 2026 per MNKD's latest filing, from -$40.7 million in the prior quarter.
- Over five years, Invested Capital peaked at -$34.3 million in Q3 2025 and troughed at -$215.9 million in Q2 2024.
- A 5-year average of -$116.3 million and a median of -$133.7 million in 2022 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2024 and 2025: Invested Capital plunged 38.04% in 2024, then surged 82.87% in 2025.
- A 5-year view of Invested Capital shows it stood at -$146.4 million in 2022, then gained by 2.98% to -$142.1 million in 2023, then soared by 51.6% to -$68.8 million in 2024, then surged by 40.81% to -$40.7 million in 2025, then slipped by 19.89% to -$48.8 million in 2026.
- Business Quant data shows MNKD's Invested Capital at -$48.8 million in Q1 2026, -$40.7 million in Q4 2025, and -$34.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -48.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.79 Mn |
| Dec 31, 2025 | -40.69 Mn |
| Sep 30, 2025 | -34.25 Mn |
| Jun 30, 2025 | -44.84 Mn |
| Mar 31, 2025 | -48.52 Mn |
| Dec 31, 2024 | -68.75 Mn |
| Sep 30, 2024 | -199.93 Mn |
| Jun 30, 2024 | -215.88 Mn |
| Mar 31, 2024 | -125.87 Mn |
| Dec 31, 2023 | -142.07 Mn |
| Sep 30, 2023 | -147.68 Mn |
| Jun 30, 2023 | -156.39 Mn |
| Mar 31, 2023 | -151.40 Mn |
| Dec 31, 2022 | -146.44 Mn |
| Sep 30, 2022 | -133.68 Mn |
| Jun 30, 2022 | -143.16 Mn |
| Mar 31, 2022 | -129.16 Mn |
| Dec 31, 2021 | -108.85 Mn |
| Sep 30, 2021 | -184.69 Mn |
| Jun 30, 2021 | -178.68 Mn |